Clinical Trials Directory

Trials / Completed

CompletedNCT04762615

Impact of Underlying Renal Disease and Immunosuppressive Regimen on Ovarian Reserve in Renal Patients

Impact of the Immunosuppressive Treatment, X-ray Exposition and Renal Pathology on Ovarian Reserve in Young Women

Status
Completed
Phase
Study type
Observational
Enrollment
153 (actual)
Sponsor
Wroclaw Medical University · Academic / Other
Sex
Female
Age
18 Years – 44 Years
Healthy volunteers
Not accepted

Summary

Aging, renal pathology (eg SLE, ADPKD), X-ray exposition and pharmacological treatments, especially previous strong immunosuppression, may negatively influence the ovarian reserve in childbearing age women. Anti-Müllerian hormone (AMH) is regarded as biomarker for ovarian reserve. Every female with renal disease regularly menstruating that met exclusion criteria could have participated. The aim was to assess ovarian reserve in female patients with normal menstrual cycle and kidney disease, including kidney transplant recipients.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTAMH level measurementAMH level measurement using ELISA test from blood samples

Timeline

Start date
2018-06-01
Primary completion
2019-11-10
Completion
2020-12-01
First posted
2021-02-21
Last updated
2021-02-21

Locations

1 site across 1 country: Poland

Source: ClinicalTrials.gov record NCT04762615. Inclusion in this directory is not an endorsement.